GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Across Myocardial Infarction-Defined Populations: A Systematic Review and Meta-Analysis
Am J Cardiovasc Drugs. 2026 Jul 1. doi: 10.1007/s40256-026-00809-5. Online ahead of print.ABSTRACTBACKGROUND: Patients with type 2 diabetes mellitus (T2DM) who survive myocardial infarction (MI) remain at high risk for recurrent cardiovascular events and heart failure (HF). Although glucagon-like pe

